Alkem Laboratories launches Ibuprofen, Famotidine tablets in US

The company has launched the tablets in the strength of 800 mg/26.6 mg in the United States, following an approval from the US Food and Drug Administration (FDA)
Read Article

Alkem Laboratories has launched Ibuprofen and Famotidine tablets, used to relieve the symptoms of rheumatoid arthritis and osteoarthritis, in the US market, a company statement said.

It also said that Ibuprofen and Famotidine tablets are a generic therapeutic equivalent version of Horizon Medicines LLC’s Duexis tablets.

The company has launched Ibuprofen and Famotidine tablets in the strength of 800 mg/26.6 mg in the United States, following an approval from the United States Food and Drug Administration (FDA), added the statement.

It further said that this is the first generic approval of Duexis tablets, 800 mg/26.6 mg by the US FDA.

“The launch is a subject of ongoing litigation,” it added.

Alkem LaboratoriesDuexis tabletsFamotidine TabletsHorizon MedicinesibuprofenUS FDA
Comments (0)
Add Comment